| scholarly article | Q13442814 |
| P50 | author | Jorge Eduardo Cortes | Q60320900 |
| Hagop Kantarjian | Q60394812 | ||
| Gianantonio Rosti | Q66370842 | ||
| Jane F Apperley | Q92881003 | ||
| Patricia Ault | Q114428046 | ||
| P2093 | author name string | Richard Pilot | |
| Alan Hatfield | |||
| Seonaid M Pye | |||
| P2860 | cites work | The protein kinase complement of the human genome | Q24324497 |
| The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites | Q28591000 | ||
| RTK mutations and human syndromeswhen good receptors turn bad. | Q33927296 | ||
| Candidate genes for congenital diaphragmatic hernia from animal models: sequencing of FOG2 and PDGFRalpha reveals rare variants in diaphragmatic hernia patients | Q34637401 | ||
| How long will chronic myeloid leukemia patients treated with imatinib mesylate live? | Q46463385 | ||
| Pregnancy among patients with chronic myeloid leukemia treated with imatinib | Q46919065 | ||
| Omphalocele and gastroschisis in Europe: a survey of 3 million births 1980-1990. EUROCAT Working Group. | Q51047552 | ||
| Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years. | Q54581100 | ||
| Risk factors for spontaneous abortion and its recurrence | Q68118421 | ||
| Spontaneous abortion | Q70288889 | ||
| A human YAC transgene rescues craniofacial and neural tube development in PDGFRalpha knockout mice and uncovers a role for PDGFRalpha in prenatal lung growth | Q73053917 | ||
| Placental transport in early pregnancy--a workshop report | Q79802764 | ||
| Imatinib mesylate and metabolite concentrations in maternal blood, umbilical cord blood, placenta and breast milk | Q80008605 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | imatinib | Q177094 |
| pregnancy outcome | Q66057507 | ||
| P1104 | number of pages | 4 | |
| P304 | page(s) | 5505-5508 | |
| P577 | publication date | 2008-03-05 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | The effects of imatinib on pregnancy outcome | |
| P478 | volume | 111 |
| Q52663678 | A Novel PRKAR1B-BRAF Fusion in Gastrointestinal Stromal Tumor Guides Adjuvant Treatment Decision-Making During Pregnancy. |
| Q35720048 | A case of chronic myelogenous leukemia in pregnancy characterized by a complex translocation t(9;22;11)(q34;q11.2;q13) |
| Q42756487 | A newborn with teratogenic effect of imatinib mesylate: a very rare case report |
| Q37154183 | Acute lymphoblastic leukemia in pregnancy: a case report with literature review |
| Q26782165 | An Overview and Update of Chronic Myeloid Leukemia for Primary Care Physicians |
| Q38222515 | An update on the management of hematologic malignancies in pregnancy |
| Q36094702 | Analysis of outcomes in adolescents and young adults with chronic myelogenous leukemia treated with upfront tyrosine kinase inhibitor therapy |
| Q38860947 | Anticancer drugs during pregnancy |
| Q38558498 | CML in pregnancy: A case report using leukapheresis and literature review |
| Q64103651 | Cancer During Pregnancy: The Oncologist Overview |
| Q92282088 | Cancer Treatment-Related Infertility: A Critical Review of the Evidence |
| Q34331656 | Cancer chemotherapy and pregnancy |
| Q37920757 | Cancer in pregnancy. Part I: basic diagnostic and therapeutic principles and treatment of gynecological malignancies |
| Q37920756 | Cancer in pregnancy. Part II: treatment options of breast and other non-gynecological malignancies |
| Q46461016 | Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinib |
| Q92108093 | Chemical-induced craniofacial anomalies caused by disruption of neural crest cell development in a zebrafish model |
| Q47929120 | Chronic Myeloid Leukemia-the Promise of Tyrosine Kinase Inhibitor Discontinuation. |
| Q46213854 | Chronic myelocytic leukemia in pregnancy: a case report describing successful treatment using multimodal therapy |
| Q95614708 | Chronic myeloid leukaemia |
| Q37163550 | Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet |
| Q35925580 | Chronic-phase chronic myeloid leukemia: Not always a reassuring diagnosis. |
| Q36736494 | Clinical review: kinase inhibitors: adverse effects related to the endocrine system |
| Q37793481 | Current Status of Imatinib as Frontline Therapy for Chronic Myeloid Leukemia |
| Q38859977 | Editor's Highlight: PlacentalDisposition and Effects of Crizotinib: An Ex Vivo Study in the Isolated Dual-Side Perfused Human Cotyledon. |
| Q53095313 | Effect of tyrosine kinase inhibitors on stemness in normal and chronic myeloid leukemia cells. |
| Q46608260 | Effects of chemotherapy during pregnancy on the placenta |
| Q41892316 | Epidemiological and clinical profile of patients with chronic myeloid leukemia at Health-Care Global, Bangalore Institute of Oncology |
| Q38654148 | Erythrocyte exchange and leukapheresis in pregnancy |
| Q47238424 | Experience with dasatinib and nilotinib use in pregnancy |
| Q50931842 | Favorable conception and pregnancy involving a male patient affected by chronic myeloid leukemia while taking dasatinib. |
| Q49627384 | Fertility preservation for patients with hematologic malignancies: The Korean Society for Fertility Preservation clinical guidelines |
| Q60953500 | Fetal Toxicity of Immunosuppressive Drugs in Pregnancy |
| Q38521304 | Gastrointestinal stromal tumors during pregnancy: a systematic review of an uncommon but treatable malignancy |
| Q35097858 | Genetic etiology of renal agenesis: fine mapping of Renag1 and identification of Kit as the candidate functional gene |
| Q41757658 | Germline mutations in ABL1 cause an autosomal dominant syndrome characterized by congenital heart defects and skeletal malformations |
| Q37983218 | Haematological cancers in pregnancy |
| Q26740587 | Hematologic malignancies during pregnancy: A review |
| Q37027767 | How I treat newly diagnosed chronic phase CML |
| Q33620407 | Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update |
| Q39459161 | Imatinib inhibits proliferation of human mesenchymal stem cells and promotes early but not late osteoblast differentiation in vitro |
| Q64116184 | Imatinib treatments have long-term impact on placentation and embryo survival |
| Q37193846 | Imatinib use in pregnancy |
| Q42576295 | Increasingly hard to swallow--18 years of changing tonsillectomy practice in Northern Ireland |
| Q42552235 | Management of Concurrent Pregnancy and Acute Lymphoblastic Malignancy in Teenaged Patients: Two Illustrative Cases and Review of the Literature |
| Q38594889 | Management of Hematologic Malignancies: Special Considerations in Pregnant Women |
| Q46018403 | Management of chronic myeloid leukemia in the setting of pregnancy: when is leukocytapheresis appropriate? A case report and review of the literature. |
| Q38337322 | Management of newly diagnosed chronic myeloid leukaemia during a twin pregnancy using leucapheresis: Case report and review of the literature |
| Q38879793 | Management of pregnant chronic myeloid leukemia patients |
| Q51072279 | Managing children with chronic myeloid leukaemia (CML): recommendations for the management of CML in children and young people up to the age of 18 years. |
| Q38392686 | Managing pregnancy in chronic myeloid leukaemia |
| Q33576775 | Medical treatment of mammary desmoid-type fibromatosis: which benefit? |
| Q52726498 | Melanoma and pregnancy. |
| Q42558320 | More about masitinib |
| Q33383407 | New dosing schedules of dasatinib for CML and adverse event management |
| Q37310478 | Nilotinib: a new tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia |
| Q38666371 | Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports |
| Q36928803 | Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis |
| Q37025981 | Pediatric chronic myeloid leukemia is a unique disease that requires a different approach |
| Q52938008 | Physiological measurements corroborate symptomatic improvement after therapeutic leukapheresis in a pregnant woman with chronic myelogenous leukemia. |
| Q38681424 | Placental transfer of tyrosine kinase inhibitors used for chronic myeloid leukemia treatment |
| Q92666581 | Planned Pregnancy in Female Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy |
| Q36169022 | Planned pregnancy in a chronic myeloid leukemia patient in molecular remission |
| Q42531379 | Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response |
| Q64930681 | Preclinical toxicological assessment of a novel monoclonal antibody targeting human platelet-derived growth factor CC (PDGF-CC) in PDGF-CChum mice. |
| Q90482324 | Pregnancy Outcomes in Chronic Myeloid Leukemia: A Single Center Experience |
| Q36795494 | Pregnancy and Accelerated Phase of Myeloid Chronic Leukemia Treated with Imatinib: A Case Report from a Developing Country. |
| Q43901048 | Pregnancy outcome in chronic myeloid leukemia patients on imatinib therapy |
| Q51184825 | Pregnancy outcomes in patients with chronic myeloid leukemia treated with imatinib mesylate: short report from a developing country. |
| Q50545595 | Pregnancy with metastatic gastrointestinal stromal tumor (GIST) on imatinib chemotherapy: an oncologist's nightmare and obstetrician's dilemma. |
| Q54186045 | Pregnancy: part of life in chronic myelogenous leukemia. |
| Q34443523 | Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase |
| Q36880864 | Quality of Life and Long-Term Therapy in Patients with Chronic Myeloid Leukemia |
| Q38937497 | Rationale and motivating factors for treatment-free remission in chronic myeloid leukemia |
| Q38813874 | Recognizing Endocrinopathies Associated With Tyrosine Kinase Inhibitor Therapy in Children With Chronic Myelogenous Leukemia |
| Q37517600 | Report of chronic myeloid leukemia from SEAROC experience, Jaipur over a period of 9 years |
| Q23923997 | Safe handling of oral antineoplastic medications: focus on targeted therapeutics in the home setting |
| Q35130023 | Successful Management of Pregnancy and Hepatic Toxicity in a CML Female Patient Treated with Nilotinib: a Case Report and a Review. |
| Q93022033 | Successful Management of a Pregnant Patient With Chronic Myeloid Leukemia Receiving Standard Dose Imatinib |
| Q92619772 | Successful Planned Pregnancy through Vitrified-Warmed Embryo Transfer in a Woman with Chronic Myeloid Leukemia: Case Report and Literature Review |
| Q33708377 | Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy. |
| Q37459133 | Successful pregnancy and delivery in a patient with chronic myeloid leukemia: a case report and review of the literature |
| Q34523506 | Successful pregnancy in a patient with chronic myeloid leukaemia exposed to dasatinib during the first trimester |
| Q45833965 | Successful treatment of a pregnant woman with Philadelphia chromosome-positive acute lymphoblastic leukemia |
| Q54159785 | Teratogenic Effect of Radotinib: Case Report. |
| Q55395798 | The Wave2 scaffold Hem-1 is required for transition of fetal liver hematopoiesis to bone marrow. |
| Q37423501 | The impact of dasatinib on pregnancy outcomes |
| Q35634865 | The role of stem cell transplantation for chronic myelogenous leukemia in the 21st century |
| Q41680312 | The teratogenic effects of imatinib mesylate on rat fetuses |
| Q30754830 | The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad |
| Q34299317 | The treatment of hematologic malignancies in pregnancy |
| Q41534360 | Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia in pregnancy |
| Q37994805 | Treatment options for chronic myeloid leukemia |
| Q94592372 | Treatment-free remission in patients with chronic myeloid leukaemia |
| Q58609173 | Treatment-free remission with first- and second-generation tyrosine kinase inhibitors |
| Q38074219 | Twin pregnancy and childbirth after reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation combined with imatinib mesylate for chronic myeloid leukaemia: case report and literature review |
| Q37389662 | Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study |
| Q60921654 | Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience |
| Q33568481 | Tyrosine kinase inhibitors and pregnancy |
| Q26766236 | Tyrosine kinase inhibitors and pregnancy: A risk to the fetus? |
| Q35584349 | Will imatinib compromise reproductive capacity? |
| Q89550084 | [Effect of nilotinib on pregnancy outcome in female patients with chronic myeloid leukemia] |
| Q33667001 | c-Abl tyrosine kinase regulates cardiac growth and development |
Search more.